| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016911 |
| Receipt No. | R000019624 |
| Scientific Title | A prospective randomized comparative trial of covered self-expandable metallic stents with 12mm and 10mm diameters for the distal biliary obstructions in unresectable malignancies |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2020/09/26 (Ver. 7) |
| Basic information | ||
| Public title | A prospective randomized comparative trial of covered self-expandable metallic stents with 12mm and 10mm diameters for the distal biliary obstructions in unresectable malignancies | |
| Acronym | A prospective RCT of covered SEMS with 12mm and 10mm diameters for the distal biliary obstructions in unresectable malignancies (BORE Study) | |
| Scientific Title | A prospective randomized comparative trial of covered self-expandable metallic stents with 12mm and 10mm diameters for the distal biliary obstructions in unresectable malignancies | |
| Scientific Title:Acronym | A prospective RCT of covered SEMS with 12mm and 10mm diameters for the distal biliary obstructions in unresectable malignancies (BORE Study) | |
| Region |
|
|
| Condition | ||
| Condition | unresectable distal biliary malignancies | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the efficacy and safety of covered metallic stent between 12mm and 10 mm diameters for unresectable distal malignant biliary obstructions. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Stent occlusion rate and dysfunction rate at 180 days after stent deployment |
| Key secondary outcomes | 1) Stent patency duration
2) Time to recurrent biliary obstruction (TRBO) 3) Overall stent patency rate and function rate 4) Median survival time 5) Stent-related complication rate |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Covered biliary metallic stent with a 10-mm diameter | |
| Interventions/Control_2 | Covered biliary metallic stent with a 12-mm diameter | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients
1) with unresectable malignant distal biliary obstruction (> 2 cm distal to the biliary hilum) 2) expected prognosis more than 2 months 3) 20 years old 4) Eastern Cooperative Oncology Group Performance Status (ECOG-PS) < grade 2 5) obtained written informed consent. |
|||
| Key exclusion criteria | 1) patients with massive ascites
2) patients with severe comorbidities in other organs 3) prior biliary SEMS placement 4) patients with surgically altered anatomy 5) difficulty to achieve biliary cannulation during endoscopic retrograde cholangiography 6) intestinal obstruction distal to the ampulla 7) patients with pregnancy 8) patients considered ineligible by attending physicians |
|||
| Target sample size | 74 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gifu Municipal Hospital | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 500-8513 | ||||||
| Address | 7-1 Kashima-cho, Gifu, Japan | ||||||
| TEL | 058-251-1101 | ||||||
| tsuyomukai@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gifu Municipal Hospital | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 500-8513 | ||||||
| Address | 7-1 Kashima-cho, Gifu, Japan | ||||||
| TEL | 058-251-1101 | ||||||
| Homepage URL | http://gmhosp.jp/about-index/rinrishinsa/rinrishinsa-02.html | ||||||
| tsuyomukai@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | BORE Study Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Gifu Municipal Hospital |
| Address | 7-1 Kashima-cho, Gifu, Japan |
| Tel | 058-251-1101 |
| tsuyomukai@yahoo.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 1) 岐阜市民病院 消化器内科
Department of Gastroenterology, Gifu Municipal Hospital, Gifu 2) 岐阜大学 第一内科 First Department of Internal Medicine, Gifu University Hospital, Gifu 3) 岐阜県総合医療センター 消化器内科 Department of Gastroenterology, Gifu Prefectural General Medical Center, Gifu 4) 岐北厚生病院 消化器内科 Department of Gastroenterology, Gihoku Kosei Hospital, Yamagata 5) 羽島市民病院 消化器内科 Department of Gastroenterology, Hashima Municipal Hospital, Hashima 6) 帝京大学附属溝口病院 消化器内科 Department of Gastroenterology, Teikyo University Mizonokuchi Hospital, Kawasaki 7) 東京大学 消化器内科 Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://gmhosp.jp/about-index/rinrishinsa/rinrishinsa-02.html |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019624 |